StockData
Hims & Hers Health, Inc. logo

Hims & Hers Health, Inc. (HIMS) shareholders

HIMSNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/30171% above fair value
$17.55−1.01 (-5.44%)

Close on Nov 17, 2026Market cap $4.09BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
67.1%
157M of 233M shares
Institutional holders
506
143 new, 66 sold out
Net institutional buying
7M
In Q2 2026
Insider trades, 12 months
1 buys · 44 sales
Net sold $17.24M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.26,496,21811.90%13G (passive) amendmentJun 30, 2026
Andrew Dudum22,610,0029.40%13D (active) amendmentAug 27, 2026
Susquehanna Securities, LLC
Joint filing with G1 Execution Services, LLC (6.50%), SIG Brokerage, LP (6.50%) and 1 more
14,502,3956.50%13G (passive)Mar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of HIMSValueChange% of portfolio
BlackRock, Inc.28,703,51412.30%$995.15M+2,366,3560.01%
Vanguard Portfolio Management LLC10,559,3144.53%$366.09M+375,5010.02%
Vanguard Capital Management LLC9,541,3844.09%$330.80M+201,6730.01%
State Street Corp8,145,6993.49%$282.41M+685,6760.01%
Morgan Stanley7,152,4983.07%$247.98M−1,736,5900.01%
Divisadero Street Capital Management, LP6,009,5052.58%$208.35M+5,539,6724.72%
Geode Capital Management, LLC5,681,8322.44%$197.02M+483,0530.01%
Goldman Sachs Group Inc5,173,8652.22%$179.38M+2,719,1700.02%
JPMorgan Chase & Co4,766,7812.04%$159.48M−474,0350.01%
FMR LLC4,323,2921.85%$149.89M+4,230,0220.01%
Marshall Wace, Llp4,217,7671.81%$146.23M+3,493,5400.12%
UBS Group AG2,660,8101.14%$92.25M−1,490,8280.01%
Northern Trust Corp2,594,2771.11%$89.94M+158,2480.01%
Charles Schwab Investment Management Inc2,453,7871.05%$85.07M+95,0730.01%
State Of Michigan Retirement System2,346,2821.01%$81.35M+7,6820.36%
Bank Of America Corp /De/2,312,2720.99%$80.17M−2,045,4000.01%
Principal Financial Group Inc1,667,0730.71%$57.80M+384,8070.03%
Vanguard Fiduciary Trust Co1,522,2490.65%$52.78M+72,8640.01%
Bank of New York Mellon Corp1,333,1460.57%$46.22M−7,3000.01%
Schroder Investment Management Group1,129,7810.48%$37.72M+397,0150.03%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026506157M67.1%143 / 179130 / 6637M30M
Q1 2026436149M64.0%83 / 159142 / 12752M65M
Q4 2025487184M78.7%99 / 178161 / 12021M55M
Q3 2025512218M93.4%103 / 201153 / 9565M21M
Q2 2025510176M75.3%141 / 187143 / 5640M25M
Q1 2025430160M68.6%118 / 146142 / 7334M36M
Q4 2024394165M70.6%133 / 129108 / 4262M37M
Q3 2024308140M59.9%65 / 10391 / 4940M23M
Q2 2024297139M59.4%98 / 10963 / 4144M38M
Q1 2024243133M57.1%81 / 7066 / 3335M28M
Q4 2023197126M54.1%38 / 7157 / 2922M15M
Q3 2023191119M51.0%33 / 7257 / 2910M23M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

321 funds held HIMS in Q2 2026, 75% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of HIMSValue% of fundAs of
iShares Core S&P Mid-Cap ETF7,252,5293.11%$251.45M0.20%Jun 30, 2026
Vanguard Total Stock Market Index Fund6,715,8132.88%$232.84M0.01%Jun 30, 2026
iShares Russell 2000 ETF5,547,2452.38%$192.32M0.23%Jun 30, 2026
Vanguard Small-Cap Index Fund4,861,8922.08%$168.56M0.09%Jun 30, 2026
Vanguard Small-Cap Growth Index Fund2,801,1081.20%$97.11M0.21%Jun 30, 2026
Vanguard Extended Market Index Fund2,434,6221.04%$84.41M0.09%Jun 30, 2026
Fidelity Small Cap Index Fund2,362,4811.01%$65.61M0.19%Jul 31, 2026
iShares Russell 2000 Growth ETF1,995,0340.86%$69.17M0.45%Jun 30, 2026
JPMorgan Large Cap Growth Fund1,976,9390.85%$68.54M0.06%Jun 30, 2026
iShares S&P Mid-Cap 400 Growth ETF1,268,5020.54%$43.98M0.39%Jun 30, 2026
Fidelity Small Cap Growth Fund1,229,4200.53%$34.14M0.39%Jul 31, 2026
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF1,074,0270.46%$37.24M0.20%Jun 30, 2026
Fidelity Extended Market Index Fund1,072,8000.46%$28.05M0.07%May 31, 2026
Vanguard Russell 2000 Index Fund1,053,6650.45%$27.55M0.16%May 31, 2026
Schwab U.S. Small-Cap ETF999,1470.43%$26.13M0.11%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Deborah M. AutorChief Policy Officer, Director72,7890.03%Nov 17, 2026
Andrew DudumChief Executive Officer, Director, 10% owner16,686,9487.15%Nov 17, 2026
Soleil BoughtonChief Legal Officer314,6480.13%Nov 17, 2026
Patrick Harrison CarrollChief Medical Officer213,5740.09%Nov 17, 2026
Michael ChiChief Operating Officer487,8480.21%Nov 17, 2026
Oluyemi OkupeChief Financial Officer277,5590.12%Nov 17, 2026
Mohamed ElshenawyCTO278,0440.12%Nov 17, 2026
Jonathan M. FranklinChief Accounting Officer––Nov 13, 2026
Irene BecklundPAO20,4750.01%Aug 18, 2026
Nader KabbaniChief Operating Officer––May 20, 2025
Melissa BairdChief Operating Officer817,8290.35%May 13, 2025
David B. WellsDirector230,8590.10%Nov 17, 2026
Christopher D. PayneDirector145,6730.06%Nov 17, 2026
Andrew D. HubermanDirector––Nov 13, 2026
Kare SchultzDirector26,0200.01%Aug 18, 2026
Kofi Owusu Amoo-GottfriedDirector––Aug 14, 2026
Anja ManuelDirector38,6710.02%Aug 14, 2026
Garcia Andrea G. PerezDirector83,8220.04%Aug 14, 2026
Delos M. CosgroveDirector67,9950.03%Aug 14, 2026
Christiane PendarvisDirector55,4300.02%Jun 15, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Mohamed Elshenawy
CTO
Nov 13, 2026Tax withholding−95,798$19.73$1.89M278,044
Mohamed Elshenawy
CTO
Nov 13, 2026Option exercise+188,286––373,842
Michael Chi
Chief Operating Officer
Nov 13, 2026Tax withholding−38,581$19.73$761.20K487,848
Michael Chi
Chief Operating Officer
Nov 13, 2026Option exercise+69,769––526,429
Oluyemi Okupe
Chief Financial Officer
Nov 13, 2026Tax withholding−36,437$19.73$718.90K269,706
Oluyemi Okupe
Chief Financial Officer
Nov 13, 2026Option exercise+71,616––306,143
Deborah M. Autor
Chief Policy Officer, Director
Nov 13, 2026Tax withholding−16,146$19.73$318.56K72,789
Deborah M. Autor
Chief Policy Officer, Director
Nov 13, 2026Option exercise+39,974––88,935
Patrick Harrison Carroll
Chief Medical Officer
Nov 13, 2026Tax withholding−10,200$19.73$201.25K213,574
Patrick Harrison Carroll
Chief Medical Officer
Nov 13, 2026Option exercise+25,927––223,774
Soleil Boughton
Chief Legal Officer
Nov 13, 2026Tax withholding−21,500$19.73$424.20K314,648
Soleil Boughton
Chief Legal Officer
Nov 13, 2026Option exercise+42,262––336,148
Andrew Dudum
Chief Executive Officer, Director, 10% owner
Nov 13, 2026Tax withholding−78,857$19.73$1.56M1,109,310
Andrew Dudum
Chief Executive Officer, Director, 10% owner
Nov 13, 2026Option exercise+154,990––1,188,167
Christopher D. Payne
Director
Nov 13, 2026Option exercise+810––35,673
David B. Wells
Director
Nov 13, 2026Option exercise+1,051––230,859
Soleil Boughton
Chief Legal Officer
Oct 28, 2026Sale(10b5-1 plan)−3,462$27.60$95.55K293,886
Soleil Boughton
Chief Legal Officer
Oct 14, 2026Sale(10b5-1 plan)−3,461$29.06$100.58K297,348
Oluyemi Okupe
Chief Financial Officer
Oct 1, 2026Sale(10b5-1 plan)−2,000$29.70$59.40K234,527
Soleil Boughton
Chief Legal Officer
Sep 30, 2026Sale(10b5-1 plan)−3,461$29.17$100.96K300,809
Oluyemi Okupe
Chief Financial Officer
Sep 22, 2026Sale(10b5-1 plan)−29,277$29.95$876.85K236,527
Oluyemi Okupe
Chief Financial Officer
Sep 22, 2026Option exercise+14,000$5.01$70.14K265,804
Oluyemi Okupe
Chief Financial Officer
Sep 17, 2026Sale(10b5-1 plan)−12,313$28.82$354.86K251,804
Soleil Boughton
Chief Legal Officer
Sep 16, 2026Sale(10b5-1 plan)−6,236$27.86$173.73K304,270
Michael Chi
Chief Operating Officer
Sep 15, 2026Sale(10b5-1 plan)−14,027$28.39$398.23K456,660
Mohamed Elshenawy
CTO
Sep 15, 2026Sale(10b5-1 plan)−7,954$28.39$225.81K185,556
Soleil Boughton
Chief Legal Officer
Sep 2, 2026Sale(10b5-1 plan)−3,458$28.33$97.97K310,506
Andrew Dudum
Chief Executive Officer, Director, 10% owner
Aug 27, 2026Other−977,566––103,406
Andrew Dudum
Chief Executive Officer, Director, 10% owner
Aug 25, 2026Gift−463,289––0
Oluyemi Okupe
Chief Financial Officer
Aug 19, 2026Sale(10b5-1 plan)−4,938$29.99$148.09K264,117
Oluyemi Okupe
Chief Financial Officer
Aug 19, 2026Option exercise+4,938$5.01$24.74K269,055
Soleil Boughton
Chief Legal Officer
Aug 19, 2026Sale(10b5-1 plan)−25,111$27.55$691.81K313,964
Deborah M. Autor
Chief Policy Officer, Director
Aug 18, 2026Sale(10b5-1 plan)−16,773$27.85$467.13K48,961
Oluyemi Okupe
Chief Financial Officer
Aug 17, 2026Sale(10b5-1 plan)−9,388$27.89$261.83K264,117
Oluyemi Okupe
Chief Financial Officer
Aug 17, 2026Option exercise+9,388$5.01$47.03K273,505
Michael Chi
Chief Operating Officer
Aug 14, 2026Tax withholding−47,702$28.15$1.34M470,687
Michael Chi
Chief Operating Officer
Aug 14, 2026Option exercise+86,265––518,389
Andrew Dudum
Chief Executive Officer, Director, 10% owner
Aug 14, 2026Tax withholding−78,859$28.15$2.22M1,033,177
Andrew Dudum
Chief Executive Officer, Director, 10% owner
Aug 14, 2026Option exercise+154,993––1,112,036
Soleil Boughton
Chief Legal Officer
Aug 14, 2026Option exercise+42,261––360,575
Soleil Boughton
Chief Legal Officer
Aug 14, 2026Tax withholding−21,500$28.15$605.23K339,075
David B. Wells
Director
Aug 14, 2026Option exercise+778––229,808
Irene Becklund
PAO
Aug 14, 2026Option exercise+13,685––20,475
Irene Becklund
PAO
Aug 14, 2026Tax withholding−6,490$28.15$182.69K13,985
Deborah M. Autor
Chief Policy Officer, Director
Aug 14, 2026Tax withholding−16,147$28.15$454.54K65,734
Deborah M. Autor
Chief Policy Officer, Director
Aug 14, 2026Option exercise+32,920––81,881
Mohamed Elshenawy
CTO
Aug 14, 2026Option exercise+188,285––289,308
Mohamed Elshenawy
CTO
Aug 14, 2026Tax withholding−95,798$28.15$2.70M193,510
Christopher D. Payne
Director
Aug 14, 2026Option exercise+545––34,863
Oluyemi Okupe
Chief Financial Officer
Aug 14, 2026Option exercise+71,616––300,554
Oluyemi Okupe
Chief Financial Officer
Aug 14, 2026Tax withholding−36,437$28.15$1.03M264,117
Kare Schultz
Director
Aug 14, 2026Option exercise+6,623––26,020
Patrick Harrison Carroll
Chief Medical Officer
Aug 14, 2026Tax withholding−10,201$28.15$287.16K197,847
Patrick Harrison Carroll
Chief Medical Officer
Aug 14, 2026Option exercise+25,927––208,048
Patrick Harrison Carroll
Chief Medical Officer
Aug 14, 2026Option exercise+260––182,121
Oluyemi Okupe
Chief Financial Officer
Jul 17, 2026Option exercise+7,163$5.01$35.89K291,484
Oluyemi Okupe
Chief Financial Officer
Jul 17, 2026Sale(10b5-1 plan)−7,163$31.99$229.14K284,321
Oluyemi Okupe
Chief Financial Officer
Jul 6, 2026Sale(10b5-1 plan)−7,163$36.49$261.38K284,321
Oluyemi Okupe
Chief Financial Officer
Jul 6, 2026Option exercise+7,163$5.01$35.89K291,484
Oluyemi Okupe
Chief Financial Officer
Jun 22, 2026Sale(10b5-1 plan)−18,197$34.03$619.24K284,321

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
24.86%
52M shares short
Days to cover
5.8
At 9M shares a day
Change since last report
-3.4%
From 53M shares
Short volume, 20 days
60.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Hims & Hers Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 359,654 shares on Sep 21, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Soleil Boughton
Officer
Oct 28, 20263,462$95.55KOct 28, 2026Restricted Stock Vesting
Soleil Boughton
Officer
Oct 14, 20263,461$100.58KOct 14, 2026Restricted Stock Vesting
Oluyemi Okupe
Officer
Oct 1, 20262,000$59.40KOct 1, 2026Restricted Stock Vesting
Soleil Boughton
Officer
Sep 30, 20263,461$100.96KSep 30, 2026Restricted Stock Vesting
Oluyemi Okupe
Officer
Sep 22, 202629,277$876.85KSep 22, 2026Stock Option Exercise
Oluyemi Okupe
Officer
Sep 17, 202612,313$354.86KSep 17, 2026Restricted Stock Vesting
Soleil Boughton
Officer
Sep 16, 20266,236$173.73KSep 16, 2026Restricted Stock Vesting
Mohamed Elshenawy
Officer
Sep 15, 20267,954$225.81KSep 15, 2026Restricted Stock Vesting
Michael Chi
Officer
Sep 15, 202614,027$398.23KSep 15, 2026Restricted Stock Vesting
Soleil Boughton
Officer
Sep 2, 20263,458$97.97KSep 2, 2026Restricted Stock Vesting
Soleil Boughton
Officer
Aug 19, 202625,111$691.81KAug 19, 2026Restricted Stock Vesting
Deborah M. Autor
Officer, Director
Aug 18, 202616,773$467.13KAug 18, 2026Restricted Stock Vesting
Christiane Pendarvis
Former Director
Jul 22, 20263,500$113.28KJul 22, 2026Restricted Stock Vesting
Oluyemi Okupe
Officer
Jul 6, 202628,652$1.10MJul 6, 2026Acquired as compensation -- Stock Options
Patrick Harrison Carroll
Officer
Jun 18, 202623,726$830.41KJun 18, 2026Restricted Stock Vesting

Congress trades

2 trades in Hims & Hers Health reported by 2 members of the House

MemberTypeTradedAmountFiled
Tony Wied
WI08 · joint account
Sold (part)Dec 17, 2025$100K–250KJan 9, 2026
Lisa McClain
MI09 · spouse
BoughtAug 4, 2025$1K–15KSep 12, 2025

See a number that looks wrong?